170900.KO Dong-A St

Healthcare Pharmaceuticals Korea Stock Exchange
34,950 KRW
Close of Nov 4, 2026
31,600 55,509
Market cap
KRW 337B
P/E
38.6x
P/B
0.52x
ROE
3.5%
Dividend yield
1.87%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 170900.KO undervalued?

Graham number
Price34,950
Graham value36,965
Discount5.5%

170900.KO trades 5.5% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Dong-A St fundamental analysis

No fundamental analysis for Dong-A St yet.

Dong-A St stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Dong-A St

Dong-A ST Co., Ltd. develops, manufactures, and markets pharmaceutical products in South Korea and internationally. It offers various ethical drugs, including Clofazimine cap. for lepromatous leprosy; Closerin Cap for active pulmonary and extra-pulmonary tuberculosis; Eporon inj./PFS for anemia associated with chronic renal failure; Gemcit inj. to treat non-small cell lung, pancreatic, breast, bladder, and ovarian cancers; Gonadopin inj./PFS for ovarian hyperstimulation and …

Full company profile